Informationen: Dieses ist nicht die aktuellste Version des Datenmodells. Eine Versionsübersicht finden Sie links unter Versionen. Die aktuellste Version finden Sie hier.
Informationen:
Fehler:
ID
26885
Beschreibung
Predicting Response to Capecitabine in Women With Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00953537
Link
https://clinicaltrials.gov/show/NCT00953537
Stichworte
Versionen (2)
- 27.10.17 27.10.17 -
- 20.09.21 20.09.21 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
27. Oktober 2017
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Breast Cancer NCT00953537
Eligibility Breast Cancer NCT00953537
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Breast Cancer NCT00953537
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Secondary malignant neoplasm of female breast
Item
radiologically (by scintography) or histologically confirmed metastatic breast cancer
boolean
C0346993 (UMLS CUI [1])
Target Lesion Measurable Quantity | Target Lesion Evaluable Quantity
Item
at least 1 measurable or evaluable target lesion
boolean
C2986546 (UMLS CUI [1,1])
C1513040 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C2986546 (UMLS CUI [2,1])
C1516986 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
C1513040 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C2986546 (UMLS CUI [2,1])
C1516986 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
Capecitabine | Antiangiogenic therapy Targeted | bevacizumab | trastuzumab
Item
receiving capecitabine as monotherapy or with targeted antiangiogenic therapies (e.g., bevacizumab or trastuzumab)
boolean
C0671970 (UMLS CUI [1])
C2363719 (UMLS CUI [2,1])
C1521840 (UMLS CUI [2,2])
C0796392 (UMLS CUI [3])
C0728747 (UMLS CUI [4])
C2363719 (UMLS CUI [2,1])
C1521840 (UMLS CUI [2,2])
C0796392 (UMLS CUI [3])
C0728747 (UMLS CUI [4])
Exclusion | Metastatic malignant neoplasm to brain Uncontrolled
Item
no uncontrolled brain metastases
boolean
C2828389 (UMLS CUI [1])
C0220650 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0220650 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
Hormone Receptor Status Unspecified
Item
hormone receptor status not specified
boolean
C0019929 (UMLS CUI [1,1])
C0449438 (UMLS CUI [1,2])
C0205370 (UMLS CUI [1,3])
C0449438 (UMLS CUI [1,2])
C0205370 (UMLS CUI [1,3])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Menopausal Status Unspecified
Item
menopausal status not specified
boolean
C1513126 (UMLS CUI [1,1])
C0205370 (UMLS CUI [1,2])
C0205370 (UMLS CUI [1,2])
Life Expectancy
Item
life expectancy ≥ 3 months
boolean
C0023671 (UMLS CUI [1])
Fertility Contraceptive methods
Item
fertile patients must use effective contraception
boolean
C0015895 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0700589 (UMLS CUI [1,2])
Exclusion | Chronic disease Uncontrolled
Item
no chronic uncontrolled illness
boolean
C2828389 (UMLS CUI [1])
C0008679 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0008679 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
Exclusion | Congestive heart failure
Item
no congestive heart failure
boolean
C2828389 (UMLS CUI [1])
C0018802 (UMLS CUI [2])
C0018802 (UMLS CUI [2])
Exclusion | Peripheral venous disease
Item
no peripheral venous disease
boolean
C2828389 (UMLS CUI [1])
C0750166 (UMLS CUI [2])
C0750166 (UMLS CUI [2])
Exclusion | Communicable Disease Uncontrolled Severe
Item
no severe uncontrolled infection
boolean
C2828389 (UMLS CUI [1])
C0009450 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0205082 (UMLS CUI [2,3])
C0009450 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0205082 (UMLS CUI [2,3])
Exclusion | Hypoxemic respiratory failure
Item
no hypoxemic respiratory failure
boolean
C2828389 (UMLS CUI [1])
C0340194 (UMLS CUI [2])
C0340194 (UMLS CUI [2])
Exclusion | Primary malignant neoplasm | Exception Basal cell carcinoma
Item
no prior primary cancer except for basal cell carcinoma of the skin
boolean
C2828389 (UMLS CUI [1])
C1306459 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0007117 (UMLS CUI [3,2])
C1306459 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0007117 (UMLS CUI [3,2])
Exclusion | Mental disorders
Item
no psychologic disorder
boolean
C2828389 (UMLS CUI [1])
C0004936 (UMLS CUI [2])
C0004936 (UMLS CUI [2])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
ID.18
Item
see disease characteristics
boolean
Exclusion | Capecitabine Associated with Chemotherapy
Item
no capecitabine co-administered with chemotherapy
boolean
C2828389 (UMLS CUI [1])
C0671970 (UMLS CUI [2,1])
C0332281 (UMLS CUI [2,2])
C0392920 (UMLS CUI [2,3])
C0671970 (UMLS CUI [2,1])
C0332281 (UMLS CUI [2,2])
C0392920 (UMLS CUI [2,3])